nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—CYP2C9—Gefitinib—lung cancer	0.222	0.339	CbGbCtD
Ximelagatran—CYP2C9—Teniposide—lung cancer	0.215	0.329	CbGbCtD
Ximelagatran—CYP2C9—Paclitaxel—lung cancer	0.12	0.184	CbGbCtD
Ximelagatran—CYP2C9—Cisplatin—lung cancer	0.0965	0.148	CbGbCtD
Ximelagatran—F2—mammary gland—lung cancer	0.00173	0.297	CbGeAlD
Ximelagatran—F2—respiratory system—lung cancer	0.00115	0.198	CbGeAlD
Ximelagatran—F2—epithelium—lung cancer	0.000965	0.165	CbGeAlD
Ximelagatran—CYP2C9—mammary gland—lung cancer	0.00069	0.118	CbGeAlD
Ximelagatran—F2—bone marrow—lung cancer	0.000677	0.116	CbGeAlD
Ximelagatran—F2—lung—lung cancer	0.000613	0.105	CbGeAlD
Ximelagatran—CYP2C9—Biological oxidations—GCLC—lung cancer	0.000486	0.00143	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—AVP—lung cancer	0.000484	0.00142	CbGpPWpGaD
Ximelagatran—F2—Cell surface interactions at the vascular wall—HRAS—lung cancer	0.000482	0.00141	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—NRAS—lung cancer	0.000475	0.00139	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—lung cancer	0.000475	0.00139	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GNG11—lung cancer	0.000472	0.00138	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	0.00047	0.00138	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—RAF1—lung cancer	0.00046	0.00135	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—OXTR—lung cancer	0.000458	0.00134	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GRP—lung cancer	0.000458	0.00134	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—MAPK3—lung cancer	0.000455	0.00133	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	0.000449	0.00132	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ITGB1—lung cancer	0.000445	0.0013	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000445	0.0013	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—EGFR—lung cancer	0.000432	0.00127	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GNG11—lung cancer	0.000429	0.00126	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—ADCY1—lung cancer	0.000424	0.00124	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000422	0.00124	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000417	0.00122	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP2E1—lung cancer	0.000413	0.00121	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—IL2—lung cancer	0.000412	0.00121	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—KRAS—lung cancer	0.000409	0.0012	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP2E1—lung cancer	0.000408	0.0012	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—COL4A2—lung cancer	0.000396	0.00116	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PTHLH—lung cancer	0.000395	0.00116	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GIPR—lung cancer	0.000386	0.00113	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ADCY1—lung cancer	0.000385	0.00113	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PPP2R1B—lung cancer	0.000376	0.0011	CbGpPWpGaD
Ximelagatran—F2—Regulation of Actin Cytoskeleton—PIK3CA—lung cancer	0.000375	0.0011	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—ANXA1—lung cancer	0.000371	0.00109	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SDC4—lung cancer	0.000361	0.00106	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SRC—lung cancer	0.00036	0.00106	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PTHLH—lung cancer	0.000358	0.00105	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.000354	0.00104	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DUSP3—lung cancer	0.000353	0.00104	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—APP—lung cancer	0.000352	0.00103	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—lung cancer	0.000351	0.00103	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RHEB—lung cancer	0.000347	0.00102	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MMP1—lung cancer	0.000346	0.00101	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000346	0.00101	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTP1—lung cancer	0.000341	0.001	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	0.000339	0.000994	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ANXA1—lung cancer	0.000337	0.000988	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTP1—lung cancer	0.000336	0.000986	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—MAPK3—lung cancer	0.000332	0.000973	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—APOA1—lung cancer	0.000331	0.000971	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRM8—lung cancer	0.000328	0.000963	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000327	0.000958	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	0.000323	0.000946	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—POMC—lung cancer	0.000322	0.000943	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—APP—lung cancer	0.000319	0.000937	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SKI—lung cancer	0.000318	0.000933	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—GSTM1—lung cancer	0.000313	0.000919	CbGpPWpGaD
Ximelagatran—F2—G alpha (q) signalling events—PIK3CA—lung cancer	0.000313	0.000918	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—GSTM1—lung cancer	0.000309	0.000906	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	0.000305	0.000893	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CG—lung cancer	0.000302	0.000886	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—EGF—lung cancer	0.000299	0.000876	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP1A1—lung cancer	0.000297	0.000871	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP1A1—lung cancer	0.000293	0.000859	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CREBBP—lung cancer	0.00028	0.000822	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	0.00028	0.000821	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PXN—lung cancer	0.000276	0.00081	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	0.000274	0.000803	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AVP—lung cancer	0.000274	0.000802	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP1—lung cancer	0.000272	0.000798	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRP—lung cancer	0.000271	0.000793	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKR1C1—lung cancer	0.000271	0.000793	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—OXTR—lung cancer	0.000271	0.000793	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CD—lung cancer	0.000266	0.000779	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ALB—lung cancer	0.000262	0.000769	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—COL4A3BP—lung cancer	0.000261	0.000766	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AZIN2—lung cancer	0.000261	0.000766	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000259	0.000759	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GNG11—lung cancer	0.000253	0.000743	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CXCL8—lung cancer	0.000249	0.00073	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AVP—lung cancer	0.000248	0.000728	CbGpPWpGaD
Ximelagatran—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000248	0.000727	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000244	0.000714	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFC—lung cancer	0.000241	0.000707	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—RAF1—lung cancer	0.000237	0.000695	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000236	0.000692	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CB—lung cancer	0.000232	0.000679	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADCY1—lung cancer	0.000228	0.000668	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—POMC—lung cancer	0.000226	0.000663	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—lung cancer	0.000224	0.000656	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ATP5H—lung cancer	0.000222	0.000651	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SMARCA4—lung cancer	0.000222	0.000651	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PPP2R1B—lung cancer	0.000222	0.000651	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—POMC—lung cancer	0.000221	0.000649	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HSPB1—lung cancer	0.000214	0.000628	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—IL2—lung cancer	0.000213	0.000624	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTHLH—lung cancer	0.000212	0.000621	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—MMP2—lung cancer	0.000211	0.000618	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000204	0.000599	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ANXA1—lung cancer	0.000199	0.000584	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLBD1—lung cancer	0.000198	0.000581	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000195	0.000571	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FLT1—lung cancer	0.000193	0.000565	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CG—lung cancer	0.000191	0.00056	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—EP300—lung cancer	0.000191	0.00056	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NOTCH3—lung cancer	0.000189	0.000553	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APP—lung cancer	0.000189	0.000553	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGF9—lung cancer	0.000187	0.000549	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SRC—lung cancer	0.000186	0.000544	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—POMC—lung cancer	0.000182	0.000533	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HSD17B10—lung cancer	0.000181	0.000531	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—lung cancer	0.000181	0.00053	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JUNB—lung cancer	0.000179	0.000524	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NRAS—lung cancer	0.000178	0.000523	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CXCL8—lung cancer	0.000175	0.000513	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CG—lung cancer	0.000173	0.000509	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—MAPK3—lung cancer	0.000171	0.000501	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CKB—lung cancer	0.000168	0.000494	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CD—lung cancer	0.000168	0.000492	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—POMC—lung cancer	0.000165	0.000484	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STK11—lung cancer	0.000162	0.000476	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6R—lung cancer	0.000161	0.000472	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CNDP2—lung cancer	0.000158	0.000464	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM2—lung cancer	0.000158	0.000464	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FOXO3—lung cancer	0.000157	0.000459	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—MTMR3—lung cancer	0.000154	0.000452	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—KRAS—lung cancer	0.000154	0.000451	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAP2K1—lung cancer	0.000153	0.00045	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CD—lung cancer	0.000152	0.000447	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PGAM1—lung cancer	0.00015	0.00044	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AVP—lung cancer	0.000147	0.00043	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CB—lung cancer	0.000146	0.000429	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2A7—lung cancer	0.000143	0.00042	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IGF1R—lung cancer	0.000141	0.000414	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PIK3CA—lung cancer	0.000141	0.000414	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL8—lung cancer	0.000141	0.000412	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SDC4—lung cancer	0.00014	0.000411	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HES1—lung cancer	0.000139	0.000407	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—TP53—lung cancer	0.000137	0.0004	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—RAF1—lung cancer	0.000136	0.000399	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—IL2—lung cancer	0.000134	0.000394	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CB—lung cancer	0.000133	0.00039	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—HRAS—lung cancer	0.000131	0.000383	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL8—lung cancer	0.000128	0.000374	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA3—lung cancer	0.000128	0.000374	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—RRM1—lung cancer	0.000128	0.000374	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB3—lung cancer	0.000127	0.000372	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL2—lung cancer	0.000122	0.000358	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TERT—lung cancer	0.000122	0.000357	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—B4GALT5—lung cancer	0.00012	0.000352	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGFR1—lung cancer	0.000118	0.000346	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA4—lung cancer	0.000117	0.000342	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HIF1A—lung cancer	0.000116	0.000341	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—lung cancer	0.000115	0.000338	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000114	0.000334	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA2—lung cancer	0.000114	0.000334	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOA1—lung cancer	0.000112	0.000329	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KDR—lung cancer	0.000111	0.000326	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTA1—lung cancer	0.00011	0.000322	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCC3—lung cancer	0.000108	0.000318	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKR1C1—lung cancer	0.000105	0.000308	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CG—lung cancer	0.000102	0.0003	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KIT—lung cancer	0.000102	0.0003	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APC—lung cancer	0.000102	0.0003	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NRAS—lung cancer	0.000102	0.0003	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UGT1A1—lung cancer	0.000102	0.000299	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGF—lung cancer	0.000101	0.000297	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GNG11—lung cancer	9.84e-05	0.000288	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—MAPK3—lung cancer	9.81e-05	0.000288	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.79e-05	0.000287	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—POMC—lung cancer	9.75e-05	0.000286	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BRAF—lung cancer	9.63e-05	0.000282	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6R—lung cancer	9.51e-05	0.000279	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CREBBP—lung cancer	9.5e-05	0.000279	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALDOA—lung cancer	9.37e-05	0.000275	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—EGFR—lung cancer	9.33e-05	0.000274	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NCOA3—lung cancer	9.09e-05	0.000267	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAP2K1—lung cancer	9.06e-05	0.000266	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CD—lung cancer	9.01e-05	0.000264	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.93e-05	0.000262	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PIK3CA—lung cancer	8.92e-05	0.000262	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ADCY1—lung cancer	8.84e-05	0.000259	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCG2—lung cancer	8.84e-05	0.000259	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—KRAS—lung cancer	8.82e-05	0.000259	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ENO2—lung cancer	8.67e-05	0.000254	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HPGDS—lung cancer	8.67e-05	0.000254	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPP2R1B—lung cancer	8.62e-05	0.000253	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.5e-05	0.000249	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTT1—lung cancer	8.41e-05	0.000247	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GCLC—lung cancer	8.32e-05	0.000244	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2A6—lung cancer	8.32e-05	0.000244	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.28e-05	0.000243	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PIK3CA—lung cancer	8.1e-05	0.000238	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MDM2—lung cancer	8.07e-05	0.000237	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RAF1—lung cancer	8.04e-05	0.000236	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ERBB2—lung cancer	7.95e-05	0.000233	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ENO1—lung cancer	7.88e-05	0.000231	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.85e-05	0.00023	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MTOR—lung cancer	7.85e-05	0.00023	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CB—lung cancer	7.85e-05	0.00023	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.75e-05	0.000227	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL8—lung cancer	7.54e-05	0.000221	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HRAS—lung cancer	7.49e-05	0.00022	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—lung cancer	7.29e-05	0.000214	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP3—lung cancer	7.22e-05	0.000212	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL2—lung cancer	7.21e-05	0.000211	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6—lung cancer	7.17e-05	0.00021	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2E1—lung cancer	7.07e-05	0.000207	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCND1—lung cancer	7.03e-05	0.000206	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JUN—lung cancer	7.01e-05	0.000206	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NQO1—lung cancer	6.99e-05	0.000205	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.85e-05	0.000201	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—lung cancer	6.82e-05	0.0002	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDKN1A—lung cancer	6.8e-05	0.000199	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.78e-05	0.000199	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTEN—lung cancer	6.78e-05	0.000199	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—lung cancer	6.62e-05	0.000194	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EP300—lung cancer	6.47e-05	0.00019	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—STK11—lung cancer	6.3e-05	0.000185	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SRC—lung cancer	6.29e-05	0.000184	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—lung cancer	6.13e-05	0.00018	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—STAT3—lung cancer	6.07e-05	0.000178	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NRAS—lung cancer	6.05e-05	0.000177	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.92e-05	0.000173	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTP1—lung cancer	5.83e-05	0.000171	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MAPK3—lung cancer	5.8e-05	0.00017	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAT—lung cancer	5.67e-05	0.000166	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.64e-05	0.000165	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MYC—lung cancer	5.64e-05	0.000165	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCB1—lung cancer	5.52e-05	0.000162	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—EGFR—lung cancer	5.51e-05	0.000162	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TYMS—lung cancer	5.42e-05	0.000159	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GSTM1—lung cancer	5.36e-05	0.000157	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KRAS—lung cancer	5.21e-05	0.000153	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP1A1—lung cancer	5.08e-05	0.000149	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ERCC2—lung cancer	5.04e-05	0.000148	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PIK3CA—lung cancer	4.78e-05	0.00014	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TP53—lung cancer	4.63e-05	0.000136	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HRAS—lung cancer	4.43e-05	0.00013	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOA1—lung cancer	4.36e-05	0.000128	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6—lung cancer	4.24e-05	0.000124	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.17e-05	0.000122	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CG—lung cancer	3.98e-05	0.000117	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—lung cancer	3.91e-05	0.000115	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—POMC—lung cancer	3.79e-05	0.000111	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CREBBP—lung cancer	3.69e-05	0.000108	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CD—lung cancer	3.5e-05	0.000103	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALB—lung cancer	3.45e-05	0.000101	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CB—lung cancer	3.05e-05	8.94e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—lung cancer	3.02e-05	8.86e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTEN—lung cancer	2.63e-05	7.73e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—EP300—lung cancer	2.51e-05	7.37e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PIK3CA—lung cancer	1.86e-05	5.45e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—lung cancer	1.52e-05	4.45e-05	CbGpPWpGaD
